Search

everythinglearnresearchcommunity

for

Search:↓

The anti-viral drug Elvitegravir may protect brain cells from damage related to neurodegenerative diseases.

Cladribine has known risks and potential new safety concerns, requiring careful monitoring.

Permanent micropigmentation can help cancer survivors feel better about themselves by restoring eyebrows lost during chemotherapy.

Mesotherapy is a promising alternative to minoxidil for hair loss with mild side effects.

Some drugs can cause rare but potentially deadly skin reactions, and early treatment and avoiding the drug again are key.

CRPS I is complex, linked to immune and nerve issues, and needs comprehensive treatment.

The guidelines recommend informed consent for gender-affirming treatments and stress the importance of personalized, culturally sensitive care for transgender individuals.

The Rotterdam Study investigates diseases in older adults and has produced many research findings.

COVID-19 leaves 80% of patients with long-term symptoms like fatigue and headaches.

The guideline recommends mental health involvement in diagnosing gender identity disorder and outlines hormone and surgical treatment protocols, emphasizing safety, informed consent, and long-term monitoring.

Histone demethylases can change gene expression and may be linked to diseases like cancer.

The European Society of Endocrinology advises individualized long-term management for PCOS, focusing on lifestyle changes, accurate diagnosis, and treatments for associated health risks and symptoms.

Anabolic steroids can build muscle and strength but have risks and need more research on their clinical benefits and side effects.

Cushing's syndrome can cause serious health problems, and early treatment is crucial, but some issues may remain after treatment.

Childhood obesity is rising globally due to various factors, and early prevention and healthy lifestyle changes are crucial.

The research found that PCOS has common genetic factors regardless of how it is diagnosed and is linked to metabolic and reproductive issues.

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

Tofacitinib is effective and safe for severe hair loss, but full regrowth is less likely after 10 years of hair loss.

The report recommends personalized treatment for women's sexual dysfunctions and more research on effective therapies.

The method can effectively extract biomedical information without needing expert annotation, performing better than previous models.

Hormone therapy for trans individuals is effective and generally safe in the short term.

Erectile dysfunction is increasingly common in men under 40, with many physical and psychological causes, and various treatment options available.

Women with PCOS have lower quality of life, especially in mental health and energy, and managing weight can help improve it.

Hormone treatments for transgender individuals generally improve mental health and physical transition, with some health risks that require medical supervision.

Testosterone therapy in transgender men has both desired effects like increased muscle mass and potential health risks such as higher cardiovascular risk.

The guideline offers practical advice for diagnosing and treating Post-COVID/Long-COVID.

Hormone therapy is essential for transgender individuals but requires careful management due to possible metabolic effects.

Use minoxidil for hair loss treatment; assess results after 6 months.

Tofacitinib helped regrow hair in most adolescents with alopecia areata, but more research is needed.

Tofacitinib may help treat severe hair loss, but more research is needed.